These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18499572)

  • 1. Does thrombolytic therapy facilitate or foil primary PCI?
    Leopold JA
    N Engl J Med; 2008 May; 358(21):2277-9. PubMed ID: 18499572
    [No Abstract]   [Full Text] [Related]  

  • 2. PCI at non-PCI centres: immediate or rescue?
    Danchin N; Armstrong PW
    Lancet; 2008 Feb; 371(9612):534-6. PubMed ID: 18280311
    [No Abstract]   [Full Text] [Related]  

  • 3. Facilitated PCI in patients with ST-elevation myocardial infarction.
    Ellis SG; Tendera M; de Belder MA; van Boven AJ; Widimsky P; Janssens L; Andersen HR; Betriu A; Savonitto S; Adamus J; Peruga JZ; Kosmider M; Katz O; Neunteufl T; Jorgova J; Dorobantu M; Grinfeld L; Armstrong P; Brodie BR; Herrmann HC; Montalescot G; Neumann FJ; Effron MB; Barnathan ES; Topol EJ;
    N Engl J Med; 2008 May; 358(21):2205-17. PubMed ID: 18499565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The FINESSE trial].
    Petronio AS; Piscione F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):1-5. PubMed ID: 19292014
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.
    Di Mario C; Dudek D; Piscione F; Mielecki W; Savonitto S; Murena E; Dimopoulos K; Manari A; Gaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M;
    Lancet; 2008 Feb; 371(9612):559-68. PubMed ID: 18280326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling drug and catheter therapy for myocardial infarction.
    Lincoff AM
    JAMA; 2004 Feb; 291(8):1000-2. PubMed ID: 14982917
    [No Abstract]   [Full Text] [Related]  

  • 7. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
    Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
    Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours.
    Maioli M; Gallopin M; Leoncini M; Bellandi F; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):484-91. PubMed ID: 15973688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
    Wong A; Mak KH; Chan C; Koh TH; Lau KW; Lim TT; Lim ST; Wong P; Sim LL; Lim YT; Tan HC; Lim YL
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):445-52. PubMed ID: 15274152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
    Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
    Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitated PCI for ST segment elevation myocardial infarction.
    Young JJ
    J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663
    [No Abstract]   [Full Text] [Related]  

  • 12. Facilitated PCI: crossing the bridge with lessons learned.
    Mishra S; Bahl VK
    Indian Heart J; 2009; 61(5):410-2. PubMed ID: 20635753
    [No Abstract]   [Full Text] [Related]  

  • 13. The CAPTIM study.
    Dudek D; Kaluza GL; Zmudka K; Tracz W; Dubiel JS;
    Lancet; 2003 Feb; 361(9358):700-1; author reply 701. PubMed ID: 12606193
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosing regimen of reteplase and costeffectiveness.
    Hödl R; Kraxner W; Maier R; Klein W
    Lancet; 2001 Oct; 358(9291):1462. PubMed ID: 11705534
    [No Abstract]   [Full Text] [Related]  

  • 15. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
    Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A;
    JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide assay value small in assessing hypertrophic cardiomyopathy.
    SoRelle R
    Circulation; 2004 Mar; 109(8):e9013-4. PubMed ID: 14993149
    [No Abstract]   [Full Text] [Related]  

  • 17. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction.
    Weinstock BS
    J Invasive Cardiol; 2002 Feb; 14(2):100-4; quiz 104-5. PubMed ID: 11818648
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
    Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ;
    J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioplasty in acute myocardial infarction after low-dose alteplase and abciximab in transferred patients. A comparison with primary angioplasty on site.
    Manari A; Guiducci V; Muià N; Giacometti P; Fioroni S; Navazio A; Gambarati G; Bendinelli S; Bruno G
    Ital Heart J; 2003 May; 4(5):311-7. PubMed ID: 12848087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.